Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial-Reference-Cited by-同舟云学术

Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial

Published:2020-06-15 Issue:12 Volume:201 Page:1488-1498
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Hayashi Hiroaki¹²,Fukutomi Yuma¹^ORCID,Mitsui Chihiro¹,Kajiwara Keiichi¹,Watai Kentaro¹^ORCID,Kamide Yosuke¹,Nakamura Yuto¹³,Hamada Yuto¹³,Tomita Yasuhiro¹²,Sekiya Kiyoshi¹,Tsuburai Takahiro¹⁴,Izuhara Kenji⁵,Wakahara Keiko²^ORCID,Hashimoto Naozumi²,Hasegawa Yoshinori²,Taniguchi Masami¹⁶

Affiliation:

1. Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan

2. Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan

3. Department of Allergy and Clinical Immunology, Juntendo University Graduate School of Medicine, Tokyo, Japan

4. Department of Respiratory Medicine, St. Marianna University School of Medicine, Yokohama City Seibu Hospital, Yokohama, Japan

5. Division of Medical Biochemistry, Department of Biomolecular Sciences, Saga Medical School, Saga, Japan; and

6. Center for Immunology and Allergology, Shonan Kamakura General Hospital, Kamakura, Japan

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference53 articles.

1. Aspirin-Exacerbated Respiratory Disease — New Prime Suspects

2. Aspirin-Exacerbated Respiratory Disease

3. Diagnosis and management of NSAID ‐Exacerbated Respiratory Disease (N‐ ERD )—a EAACI position paper

4. Urinary Leukotriene E4Concentrations Increase after Aspirin Challenge in Aspirin-sensitive Asthmatic Subjects

5. Elevated Total Serum IgE in Nonatopic Patients with Aspirin-exacerbated Respiratory Disease

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. History of Aspirin-Exacerbated Respiratory Disease: Discovery, Clinical Features, and Treatment;The Journal of Allergy and Clinical Immunology: In Practice;2024-08

2. Biologics in Aspirin-Exacerbated Respiratory Disease and Allergic Bronchopulmonary Aspergillosis;Immunology and Allergy Clinics of North America;2024-08

3. Dupilumab dampens mucosal type 2 response during acetylsalicylic acid challenge in N-ERD patients;2024-06-07

4. Eosinophilic granulomatous polyangiitis with central nervous system involvement in children: a case report and literature review;Frontiers in Immunology;2024-05-15

5. Biologikatherapie bei schwer erkrankten Patienten mit „NSAID-exacerbated respiratory disease“ und stattgehabter ASS‑Desaktivierung;HNO;2024-03-11